A detailed history of Verition Fund Management LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 62,501 shares of OCUL stock, worth $528,133. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,501
Holding current value
$528,133
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.45 - $9.23 $403,131 - $576,884
62,501 New
62,501 $543,000
Q2 2023

Aug 14, 2023

BUY
$4.6 - $7.64 $252,769 - $419,818
54,950 New
54,950 $283,000
Q4 2022

Feb 14, 2023

BUY
$2.61 - $4.41 $18,982 - $32,073
7,273 Added 71.1%
17,502 $49,000
Q2 2022

Aug 15, 2022

BUY
$3.01 - $5.22 $689 - $1,195
229 Added 2.29%
10,229 $41,000
Q4 2021

Feb 14, 2022

BUY
$6.16 - $12.07 $61,600 - $120,700
10,000 New
10,000 $70,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $650M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.